MedVentive has closed a $12 million Series D round. Investors National Healthcare Services and CHV II L.P. were joined by existing investors including CHV Capital, Core Capital Partners, Excel Venture Management, HLM Venture Partners and Long River Ventures. National Healthcare Services is the investment arm of MemorialCare Health System in California. MedVentive is a provider of business and clinical intelligence and outreach applications designed to help reduce healthcare costs and improve the quality of patient care.

KPCB led a $18.6 million funding in Teladoc, the Dallas-based telehealth provider, joining existing investors Cardinal Partners, HLM Venture Partners, Trident Capital and New Capital Partners. Dana Mead from KPCB worked on the transaction for the VC.

Valeritas Inc., a Bridgewater, N.J.-based developer of drug delivery systems for the diabetes market, has raised $150 million in Series C financing. The funding will support commercialization of its V-Go disposable insulin delivery device. Welsh, Carson, Anderson & Stowe led the financing and assumes a controlling interest in Valeritas. Previous investors MPM Capital, Pitango Venture Capital, Abingworth Management, Advanced Technology Ventures, ONSET Ventures, HLM Venture Partners, Agate Medical Investments, CHL Medical Partners and Kaiser Permanente Ventures also participated.

Transcend Medical Inc., a Menlo Park, Calif.-based ophthalmic device company, has closed a second tranche of its Series B round, bringing the total to an eye-popping $51 million. Investors include Investor Growth Capital, Canaan Partners, Finistere Ventures, HLM Venture Partners, Kaiser Permanente Ventures, Latterell Venture Partners, Morgenthaler Ventures, Split Rock Partners and Technology Partners. The company says it will use the funds to develop additional infrastructure and resources for a U.S. study of its micro-stent technology. The company is focused on minimally invasive glaucoma therapies.

New Jersey-based medical device company TYRX has raised $20 million in a round led by new investor HLM Venture Partners. The company’s previous investors Clarus Ventures and North Carolina-based Pappas Ventures also contributed to the round. The financing also included $4 million in debt financing from Comerica Bank. HLM Venture Partners’ Edward Cahill joins the TYRX board as a result of the financing. Clarus Ventures has offices in Cambridge, Mass., and in San Francisco. HLM Venture Partners is based in Boston and San Francisco.

Phreesia, a New York-based patient payment collections startup that produces both hardware and software, has just closed a $20 million Series D round, led by VantagePoint Venture Partners and including Ascension Health Ventures, Polaris Venture Partners, HLM Venture Partners, Long River Ventures and BlueCross BlueShield Venture Partners. PRESS RELEASE: NEW YORK, Sept. 28 /PRNewswire/ — [...]

Seahorse Bioscience, Inc., a Billerica, Mass.-based medical instrument company, closed a $5 million round of financing. Investors in the Series D round included Commonwealth Capital Ventures, FLIR Systems Inc, Rock Maple Ventures, Life Sciences Partners, Oxford Bioscience Partners, Healthcare Ventures, New Science Ventures and HLM Venture Partners.

HLM Venture Partners has held a $65 million first close for its third fund. The Boston-based firm is targeting $200 million. It raised $216 million for a fund that closed in 2005. www.hlmventurepartners.com

TelaDoc Medical Services, a provider of telehealth medical consults, announces a $9M investment to fund its next phase of growth. Lead investor, HLM Venture Partners, was joined by healthcare specialist Cardinal Partners along with existing investor, Trident Capital. Press release: TelaDoc Medical Services (www.teladoc.com ), the nation’s leading provider of telehealth medical consults, announces a [...]

HLM Venture Partners is raising up to $200 million for its latest health fund, according to a regulatory filing. The Boston-based VC firm investors healthcare technology and services sectors. Its last fund was capped at around $215 million in 2005. www.hlmventurepartners.com